Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Narendra Modi pays...

    Narendra Modi pays maiden visit to CDRI, 3 new drugs to be introduced

    Written by Ruby Khatun Khatun Published On 2017-06-21T11:19:44+05:30  |  Updated On 21 Jun 2017 11:19 AM IST
    Narendra Modi pays maiden visit to CDRI, 3 new drugs to be introduced

    Lucknow:Prime Minister Narendra Modi recently visited the premier CSIR-Central Drugs Research Institute (CDRI) here and evinced keen interest in the research work conducted by the state-run institute.

    Soon after arriving here on a two-day visit, the prime minister flew in a chopper from the Amausi airport to the CDRI complexDuring his 40-minute stay at the institute, he took a round of the two laboratories and expressed keen interest in the research work being done in the institute.

    As he tried to understand the research work, the prime minister even used a microscope to follow the experiments.

    He also had a brief interaction with some senior scientists.

    CDRI officials briefed him about certain new drugs being developed by the institute for treatment of diseases like osteoporosis and malaria.
    Incidentally, Modi is the president of CSIR and this was his first visit to one of its labs in the country. The institute organised an exhibition for the prime minister to highlight its contributions in drug discovery and development. Modi evinced keen interest in some of the exhibits.

    Earlier, he planted a sapling of a medicinal plant in the CDRI premises, flanked by Governor Ram Naik and Chief Minister Yogi Adityanath.


    The visit of the Prime Minister was seen with the launch of three drugs that were showcased before the PM are including anti-malarial, osteoporosis and a drug to treat a blood clot.

    CDRI director Madhu Dikshit said phase 1 clinical trial for multiple doses of the anti-malarial drug has been done. It may prove to be an effective new way to treat malaria--a disease which is becoming resistant to current medications.


    For the osteoporosis drug, which has national and international patent, the clinical trial for single dose has been done, it will help in speedy bone recovery. While the institute has procured monkey for the blood clotting drug test to see the usefulness of the drugs in treating blood clotting, she added.


    The CDRI director said the Prime Minister will see the exhibition first and will make a visit to the Molecular Structural Biology Laboratory and the Natural products chemistry laboratory having 85,000 compounds. The Institute will gift painting to the PM made by scientist Sujeet Khurana.


    "He is likely to plant medicinal plant at the Maharshi Charak garden," she added.


    The institute is amongst the premier ones and has given 13 of the 20 new drugs developed there.

    anti-malarialblood clotCDRICentral Drug Research InstituteCouncil of Scientific and Industrial ResearchCSIRexhibitionJawahar Lal NehruMadhu DikshitMaharshi Charak gardenMolecular Structural Biology LaboratoryNarendra ModiosteoporosisPrime Ministerscientist Sujeet Khurana
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok